引用本文:贾莉,苗小艳,袁宏.白血病多药耐药逆转研究现状[J].大连医科大学学报,2004,26(1):.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载  
分享到: 微信 更多
白血病多药耐药逆转研究现状
贾莉, 苗小艳, 袁宏
大连医科大学,临床检验教研室,辽宁,大连,116027
摘要:
化学治疗是白血病重要的治疗手段之一.近年来新的化疗药物不断涌现,化疗方案不断更新,然而白血病总的完全缓解率和长期生存率仍然低下,就其原因,主要是白血病细胞对化疗药物的多药耐药(MDR).作者就逆转白血病MDR 方法的最新进展作一综述.
关键词:  白血病  多药耐药  逆转
DOI:10.11724/jdmu.2004.01.22
分类号:R392.1
基金项目:
Researchful actuality of multidrug resistance of leukemia
JIA Li, MIAO Xiao-yan, YUAN Hong
Department of Clinical Biochemistry,Dalian Medical University,Dalian 116027,China
Abstract:
Chemotherapy is one of the important methods of treating leukaemia. Recently the new chemotherapeutic drugs always appear endlessly, and the plan of chemotherapy update endlessly. But the total catabatic rate and viability are still low. The important reason is the multidrug resistance of leukemic cells to chemotherapeutic drugs. This article sums up the new methods of reversing leukemic MDR.
Key words:  leukaemia  multidrug resistance  reversing